Etanercept News and Updates from The Economic Times

Searched for

ETANERCEPT

These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts
Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’
Biocon Biologics launches product for autoimmune diseases in Australia

- Intas in pact with Spanish drug maker mAbxience to sell biosimilar etanercept in over 150 countries
  mAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible ...
  22 Dec, 2023, 05.50 PM IST
- Biocon Biologics completes integration of Viatris' Europe biosimilar business
  Biocon Biologics on Thursday said it has completed the integration of the acquired biosimilar business from Viatris Inc in 31 European coun...
  30 Nov, 2023, 07.30 PM IST
- Irish drug regulator clears Lupin Pune unit after virtual inspection
  Lupin’s Pune facility is known for its R&D and manufacturing work related to biosimilars.
  10 May, 2021, 12.14 PM IST
- Add Lupin, target price Rs 1060: Centrum Broking
  Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 40764.44 Crore) operating in Pharmaceuticals s...
  13 Nov, 2020, 11.57 AM IST
- Lupin posts net loss of Rs 123 crore in September quarter
  Total revenue from operations stood at Rs 4,359.65 crore for the second quarter.
  06 Nov, 2019, 05.39 PM IST
- Lupin divests Kyowa Criticare to Neopharma Group
  Shares of Lupin closed at Rs 737, up marginally by 0.02 per cent, on Thursday.
  23 Aug, 2019, 07.47 AM IST
- Lupin aims to launch new products across geographies this fiscal
  "Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market," company said.
  14 Jul, 2019, 12.30 PM IST
- Lupin Pharma gets Good Manufacturing Certificate for its biologic plant
  Biosimilar Etanercept is used to fight a range of severe auto-immune disorders.
  27 Mar, 2019, 06.42 PM IST
- Desi pharma companies top in biosimilars globally
  Biosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...
  29 Oct, 2018, 10.31 AM IST
- Biocon puts arthritis drug on backburner
  Biocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.
  11 Jul, 2018, 12.09 PM IST
- Lupin-Mylan team up for biosimilar Etanercept
  Under the terms of the agreement, Lupin will receive an up-front payment of $15 million and potential commercial milestones together with a...
  28 Jun, 2018, 07.52 PM IST
- Lupin aims to be numero uno in biosimilar etanercept in Japan
  It takes 12-13 months for the Japanese drug authorities to give product approvals.
  22 Jun, 2018, 02.09 PM IST
- Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in Japan
  Mumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
  18 Jun, 2018, 11.59 AM IST
- Lupin's JV completes global trials for RA biosimilar
  The randomised trial of 52 weeks was conducted in 11 countries and included over 500 patients, Lupin said.
  09 Feb, 2018, 03.18 PM IST
- Lupin forms Joint Venture with Japan's Yoshindo Inc
  Lupin's Etanercept biosimilar, developed by its Biotechnology Research Group in Pune will be the first product to be licensed for clinical ...
  24 Apr, 2014, 06.01 AM IST
- Lobby fears norms violation in Cipla's biosimilar drug
  A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept.
  14 May, 2013, 09.46 AM IST
- Cipla launches biosimilar for rheumatic disorders in India
  Drug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...
  17 Apr, 2013, 12.57 PM IST
Load More